Today: 21 May 2026
Target stock drops after activist buzz fades; Fed minutes set the next test for TGT

Target stock drops after activist buzz fades; Fed minutes set the next test for TGT

NEW YORK, December 29, 2025, 21:25 ET — Market closed

  • Target slid 1.4% on Monday, trimming last week’s activist-driven bounce.
  • The stock traded in a narrow range as year-end volumes stayed light.
  • Traders are watching Tuesday’s Fed minutes and any next steps from the reported activist stake.

Target Corporation (TGT) shares fell 1.4% on Monday to $98.10, after trading between $97.72 and $100.20 in a muted year-end session. About 8.8 million shares changed hands.

The pullback matters because investors are recalibrating expectations around what, if anything, could force a faster turnaround at the big-box retailer as 2026 approaches.

A late-week report has kept the stock in focus. The Financial Times reported Friday that activist investor Toms Capital Investment Management — a shareholder that pushes for strategic changes — made a significant investment in Target, though the size of the stake and any demands were not disclosed. Target said its “top priority is getting back to growth” after three straight quarters of falling comparable sales, a gauge of performance at established stores. Retail analyst Neil Saunders of GlobalData wrote that “Financial games and monetization do not take Target in the right direction.” Reuters

The broader tape was not supportive. Wall Street’s main indexes ended lower as heavyweight technology shares retreated from last week’s rally, with the Dow down 0.51%, the S&P 500 off 0.35% and the Nasdaq down 0.5% in a holiday-shortened week that leaves investors watching Fed minutes and jobless claims.

Retail peers were mixed on the day, with Walmart up 0.7%, Costco down 0.6% and Amazon off 0.2%.

For Target, the retreat leaves the stock trading more on sentiment than fresh company headlines, with investor attention split between activist pressure and macro-driven risk appetite.

Before next session, investors will focus on the Federal Reserve’s minutes from its December meeting, due at 2 p.m. ET on Tuesday.

Target’s investor-relations events calendar showed no upcoming events scheduled. Wall Street tracking services expect the company to report again in early March, based on past reporting patterns.

On the charts, Target is trading above its 50-day moving average of about $92.5 and just above its 200-day average near $96.1 — moving averages are trend lines that smooth out day-to-day price swings. The stock’s 52-week range is $83.44 to $145.08.

Those reference points give traders clear levels to watch if volatility returns, particularly if a break below the longer-term average pulls in sellers.

Any clearer disclosure of Toms Capital’s position, or an explicit set of demands, would be the next stock-specific catalyst investors are watching as Target heads into its CEO transition early in 2026.

Until then, Target shares are likely to trade with the market, with Fed commentary and thin year-end positioning driving day-to-day swings more than company fundamentals.

Stock Market Today

  • SkinKandy Shares Rise on ASX Debut, Surpassing IPO Price
    May 21, 2026, 1:10 AM EDT. SkinKandy (SK1 ASX), Australia's largest piercing chain, saw its shares rise above the offer price following its debut on the Australian Securities Exchange (ASX). Despite a challenging retail environment, the private equity-backed company, operating over 100 stores and generating nearly $90 million in revenue this year, attracted investor interest. Unlike competitors focused on jewellery sales, SkinKandy stands out with its piercing services, signaling potential for long-term growth. The IPO's positive reception reflects continued investor appetite for growth-focused retail listings amid broader market caution.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes
Previous Story

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 30.12.2025

Go toTop